AbbVie Inc. — FDA Class III (D-0551-2026)

AbbVie Inc. is recalling 2,736 bottles of an ophthalmic human prescription drug due to failed stability specifications. This recall is classified as a Class II recall. The affected products are distributed across the United States.

• •AbbVie Inc. recalls 2,736 bottles of a human prescription drug.
• •The recall is due to failed stability specifications.
• •This is classified as a Class II recall.
• •The affected products are distributed nationwide.
• •Recalls like this can impact patient safety.

Patients using the affected drug should check their supplies, as 2,736 bottles are recalled due to stability issues. This could impact the drug's effectiveness.